Licensing & Royalties   Flowchart of the Licensing Process Federal Register Notices [Announcing the prospective grant of exclusive licenses] NIH Royalties Program Flowchart of the Licensing Process STEP 1: Select the area of technology that interests you. You can choose from: Cancer Central Nervous System Dental Technology Devices/Instrumentation Gene Based Therapies Infectious Diseases Internal Medicine Miscellaneous Ophthalmology Research Materials STEP 2: Find the specific technology you would like to license. To do so: Review the complete listing of abstracts online. STEP 3: Select the type of license you require For more information, read about the various types of licenses available STEP 4: Contact a Licensing Specialist Names and contact information are indicated on each abstract online. Click here to view a sample abstract See the latest list of abstracts online SAMPLE ABSTRACT Mouse Model of PRKAR1A Down-Regulation Description of Invention: The invention represents the first animal model of cyclic AMP (cAMP)-induced tumorigenesis, and the first animal model of protein kinase A (PKA)-related tumorigenesis. The cAMP/PKA system is of seminal importance for cellular function and signaling, and is involved in many systems and diseases. This discovery is expected to facilitate the development of drugs useful in treating endocrine and other tumors. Inventors: Constantine Stratakis et al. (NICHD) Patent Status: HHS Reference No. E-266-2004/0—Research Tool Portfolios: Cancer-Research Materials For Additional Information Please Contact: Mojdeh Bahar J.D. NIH Office of Technology Transfer 6011 Executive Blvd, Suite 325 Rockville, MD 20852-3804 Phone: 301-435-2950 E-mail: Mojdeh Bahar Fax: 301-402-0220 STEP 5: Fill out a Formal Application for a License Click here to download the Application for License A Confidential Disclosure Agreement is required for unpublished Patent Applications STEP 6: Submit Your Application Please follow the instructions on the License Application STEP 7: Negotiate Licensing Terms Speak with the appropriate Licensing Specialist listed on the abstract. Names and contact information are indicated on each abstract online. Click here to view a sample abstract STEP 7.1: If You Want a Non-Exclusive License Complete negotiations for a Non-Exclusive Patent License Agreement STEP 7.2: If You Want an Exclusive License Complete negotiations for an Exclusive Patent License Agreement OTT will publish a notice of your application in the Federal Register Other organizations have 60 days to submit comments or apply themselves STEP 7.2.A: OTT will notify you of its decision If you do not have the Acrobat Reader, please use the link below to download it now.

Note that this site uses cookies, Click here for more information.